Search
Eton Pharmaceuticals Inc
ETONAdd to Watchlist
55.610USD
0.0000.00%
Market hours 09/23, 15:59（ET）
1.52BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
-1.31%
1 Month
-12.38%
6 Months
+133.56%
Year to Date
+228.86%
1 Year
+180.43%
Key Figures
56.960Open
56.970High
0.00Volume
LossP/E TTM
23.68P/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
55.610Prev. Close
54.240Low
0.00Turnover
LossP/E Static
32.72P/B
0.00%Div Yield TTM
-1.62%ROA
66.37052wk High
0.08Volume Ratio
-3.82MNet Profit
27.39MShares
-0.0556EPS TTM
0.88Beta
-5.36%ROE
14.27052wk Low
5.59%Amplitude
67.61%Gross Margin
1.52BMarket Cap
13.15Reward/Risk
4.47%Risk Rate
Eton Pharmaceuticals Inc's Score
-0.08vs previous score
Forecast8.00
Financial Health8.40
Technical3.63
Valuation Dimensions9.28
Institutional Confidence5.00
Risk Assessment5.41
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Eton Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Neutral
Eton Pharmaceuticals Inc Latest Earnings Call Transcripts
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call: Revenue Up 99%, Guidance Raised
Eton Pharmaceuticals Q2 2026 revenue rose 99% to $37.6 million as Hemangiol led growth, while management raised 2026 revenue guidance above $145 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.42/0.11
Revenue / Forecast
37.59M/27.12M
Eton Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolETON
Number of employees31
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Opaleye Management Inc. | 10.45% |
| EcoR1 Capital, LLC | 7.42% |
| BlackRock Institutional Trust Company, N.A. | 5.74% |
| Nantahala Capital Management, LLC | 4.30% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 19.72% |
| Hedge Fund | 18.49% |
| Investment Advisor/Hedge Fund | 15.20% |
| Individual Investor | 4.94% |
Related Instruments
+1.60%
+1.61%
+0.35%
+1.18%
+0.63%
+0.23%
+0.40%
-0.40%
+0.52%
+1.19%
+2.19%
+0.59%
+0.80%
+0.30%
-0.67%
+0.30%
+1.04%
+0.42%
-1.17%
+0.69%Popular Instruments
51401.900
-88.100 (-0.17%)
30246.000
-231.900 (-0.76%)
7674.800
-32.200 (-0.42%)
14267.000
-155.000 (-1.07%)
65618.000
-511.000 (-0.77%)
6294.900
+4.900 (+0.08%)
93.853
+1.363 (+1.47%)
336.410
-0.610 (-0.18%)
221.710
-3.800 (-1.69%)
4272.100
-14.140 (-0.33%)
FAQs
What is the current price of Eton Pharmaceuticals Inc (ETON)?
The current price of Eton Pharmaceuticals Inc (ETON) is 55.61.
What is the symbol of Eton Pharmaceuticals Inc?
The ticker symbol of Eton Pharmaceuticals Inc is ETON.
What is the 52-week high of Eton Pharmaceuticals Inc?
The 52-week high of Eton Pharmaceuticals Inc is 66.37.
What is the 52-week low of Eton Pharmaceuticals Inc?
The 52-week low of Eton Pharmaceuticals Inc is 14.27.
What is the market capitalization of Eton Pharmaceuticals Inc?
The market capitalization of Eton Pharmaceuticals Inc is 1.52B.
Is Eton Pharmaceuticals Inc (ETON) currently rated as Buy, Hold, or Sell?
According to analysts, Eton Pharmaceuticals Inc (ETON) has an overall rating of Buy, with a price target of 67.50.
What is the Earnings Per Share (EPS TTM) of Eton Pharmaceuticals Inc (ETON)?
The Earnings Per Share (EPS TTM) of Eton Pharmaceuticals Inc (ETON) is -0.06.